טוען...
DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis
EZH2 is over-expressed in human colon cancer and is closely associated with tumor proliferation, metastasis and poor prognosis. Targeting and inhibiting EZH2 may be an effective therapeutic strategy for colon cancer. 3-Deazaneplanocin A (DZNep), as an EZH2 inhibitor, can suppress cancer cell growth....
שמור ב:
| הוצא לאור ב: | Acta Pharm Sin B |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4629229/ https://ncbi.nlm.nih.gov/pubmed/26579445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2015.01.011 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|